Memphis Pharmaceuticals

مادة اعلانية

Latest Update: 10 June 2025 15:27 Abu Dhabi Time.

Market Status: Closed

MPCI

Memphis Pharmaceuticals

76.07

EGP

1.030

1.37%

Open

75.04

Prev Close

75.04

PX_VOLUME

30,731

MARKET CAP (M)

DAY RANGE

75.10 - 76.35

52 WEEKS

23.93 - 84.98

Stock Statistics

Yearly Change

201.67%

Listed Shares (Million)

22.75

Earnings Multiple

4.17

Average 30-day trading volume

152,625.17

Price-to-book ratio

2.58

Earnings Per Share

11.29

Previous Dividend Distribution

3.80

Dividend Yield

5.33%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		309.36	388.26	399.66	207.33	234.79	247.14	182.65
Gross Profit		130.23	189.82	187.25	70.43	75.84	100.90	53.12
Operating Income		98.94	136.20	149.06	51.45	45.44	64.59	26.64
Profit Margin		34.81	32.77	35.24	12.10	35.56	23.52	13.56

	Period Ending:	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		871.91	663.83	551.26	518.11
Gross Profit		300.29	212.95	149.39	164.98
Operating Income		188.12	98.85	71.04	36.24
Profit Margin		21.96	13.62	13.44	8.07

Balance Sheet

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,483.67	1,343.04	1,330.93	1,217.04	1,127.34	1,004.16	795.79
Total Liabilities		823.09	960.80	1,042.41	1,067.96	1,059.62	856.04	667.63
Total Equity		660.58	382.23	288.51	149.08	67.73	148.12	128.16

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MPCI

Memphis Pharmaceuticals